Study Shows US Research Funding Declines Degrade Global Scientific Collaboration Networks
A new preprint models the global cancer science ecosystem as a multiplex network and finds that sharp declines in US Federal research funding degrade worldwide information exchange in science. The study uses a five-layer network spanning 233 countries across grants, clinical trials, co-authorships, co-inventions, and patent co-ownerships to quantify the impact. It warns that the EU and BRICS nations would face disproportionate compensatory burdens, but also identifies an opportunity to build a more resilient global research system if other countries increase international collaboration support.
Researchers have published a preprint on arXiv modeling the global cancer research ecosystem as a five-layer multiplex network connecting 233 countries and territories through grants, clinical trial co-investigations, paper co-authorships, co-inventions, and patent co-ownerships. The study focuses on the effects of sharp declines in US Federal research funding observed in 2024–25, using network efficiency as a measure of information flow across the system. Their compensation analysis framework finds that reduced US funding meaningfully degrades global scientific information exchange, with country groups such as the European Union and BRICS nations bearing outsized compensatory burdens to maintain current levels of collaboration. Despite these risks, the authors argue that if other nations increase support for international scientific partnerships, the cancer research ecosystem could be restructured to be more resilient against future funding shocks. The work builds on prior complex-network studies of global science but is novel in applying real-world shock and compensation analysis to a multilayer collaborative system. As a preprint, the findings have not yet undergone formal peer review.
What's missing
As a preprint, this study has not been peer-reviewed, and the authors' specific assumptions about the magnitude and duration of US Federal funding cuts—and how they are operationalized in the network model—are not detailed in the abstract. The study does not address potential behavioral responses by US institutions or researchers (e.g., private or philanthropic funding substitution), nor does it quantify the timeline over which compensatory burdens would need to materialize. The scope is limited to cancer science and may not generalize to other research domains.
What different sources said
- arXiv physicsCenter
Declines in research funding and science ecosystem fragility
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.